Long-term effects of nicotine on the forced swimming test in mice: An experimental model for the study of depression caused by smoke

Neurochemistry International

Volumn 49, Issue 5, 2006, Pages 481-486

  Mannucci, Carmen ^a   Tedesco, Michele ^a   Bellomo, Maria ^a   Caputi, Achille P ^a   Calapai, Gioacchino ^a  

^a UNIVERSITY OF MESSINA   (Italy)

Author keywords

Depression; Nicotine; Serotonin; Smoking

Indexed keywords

5 HYDROXYTRYPTOPHAN; N [2 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL]ETHYL] N (2 PYRIDYL)CYCLOHEXANECARBOXAMIDE; NICOTINE; SEROTONIN; SEROTONIN 1A RECEPTOR; SEROTONIN ANTAGONIST; SODIUM CHLORIDE; TOBACCO SMOKE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BEHAVIOR CHANGE; COMPARATIVE STUDY; CONTROL GROUP; CONTROLLED STUDY; DEPRESSION; DIENCEPHALON; EVALUATION; EXPERIMENTAL MODEL; FORCED SWIMMING TEST; IMMOBILIZATION; LONG TERM EXPOSURE; MEASUREMENT; MOOD DISORDER; MOUSE; NONHUMAN; PRIORITY JOURNAL; RECEPTOR UPREGULATION; SMOKING CESSATION; TASK PERFORMANCE; TOBACCO DEPENDENCE; WESTERN BLOTTING; WITHDRAWAL SYNDROME;

ANIMALS; BLOTTING, WESTERN; DEPRESSION; MALE; MICE; NICOTINE; PIPERAZINES; PYRIDINES; RECEPTOR, SEROTONIN, 5-HT1A; SEROTONIN; SEROTONIN UPTAKE INHIBITORS; SMOKE; STRESS; SUBSTANCE WITHDRAWAL SYNDROME; SWIMMING;

ANIMALIA; NICOTIANA TABACUM;

EID: 33747066418     PISSN: 01970186     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuint.2006.03.010     Document Type: Article

References (38)

1. Abe-Dohmae S., Takagi Y., and Harada N. Neurotransmitter-mediated regulation of brain aromatase: protein kinase C- and G-dependent induction. J. Neurochem. 67 5 (1996) 2087-2095
2. Artigas F., Celada P., Laruelle M., and Adell A. How does pindol improbe antidepressant action?. Trends Pharmacol. Sci. 22 (2001) 224-228
3. Balfour D.J., and Ridley D.L. The effects of nicotine on neural pathways implicated in depression: a factor in nicotine addiction?. Pharmacol. Biochem. Behav. 66 (2000) 79-85
4. Barnes N.M., and Sharp T. A review of central 5-HT receptor and their function. Neuropharmacology 38 (1999) 1083-1152
5. Calapai G., Crupi A., Firenzuoli F., Inferrera G., Squadrito F., Parisi A., De Sarro G., and Caputi A. Serotonin, norepinephrine and dopamine involvement in the antidepressant action of hipericum perforatum. Pharmacopsychiatry 34 (2001) 45-49
6. Calapai G., Squadrito F., Rizzo A., Marciano M.C., Campo G.M., and Caputi A.P. Multiple action of the coumarine derivative cloricromene and its protective effects on ischemic brain injury. Naunyn Schmiedebergs Arch. Pharmacol. 351 (1995) 209-215
7. Catania M.A., Firenzuoli F., Crupi A., Mannucci C., Caputi A.P., and Calapai G. Hypericum perforatum attenuates nicotine withdrawal syndrome in mice. Psychopharmacology 169 (2003) 186-189
8. Covey L.S. Tobacco cessation among patients with depression. Primary Care 26 (1999) 691-706
9. Covey L.S., Glassman A.H., and Stetner F. Cigarette smoking and major depression. J. Addict. Dis. 17 (1998) 35-46
10. Cryan J.F., and Leonard B.E. 5-HT1A and beyond: the role of serotonin and its receptors in depression and the antidepressant response. Hum. Psychopharmacol. 15 (2000) 113-135
11. 1A antagonist, WAY-100635, alone, and in combination with paroxetine, on olfactory bulbectomy and 8-OH-DPAT-induced changes in the rat. Pharmacol. Biochem. Behav. 63 (1999) 333-338
12. David D.J.P., Dhonnchadha B.A., Jolliet P., Hascoet M., and Bourin M. Are there gender differences in the temperature profile of mice after acute antidepressant administration and exposure to two animal models of depression?. Behav. Brain Res. 119 (2000) 203-211
13. Detke M.J., Rickels M., and Lucki I. Active behaviors in the rat forced swimming test differentially produced by serotonergic and noradrenergic antidepressants. Psychopharmacology 121 (1995) 66-72
14. Estrada-Camarena E., Fernandez-Guasti A., and Lopez-Rubalcava C. Antidepressant-like effect of different estrogenic compounds in the forced swimming test. Neuropsychopharmacology 28 5 (2003) 830-838
15. File S.E., Dinnis A.K., Heard J.E., and Irvine E.E. Mood differences between male and female light smokers and nonsmokers. Pharmacol. Biochem. Behav. 72 (2002) 681-689
16. A autoreceptors in the mechanism of action of serotoninergic antidepressant drugs: recent findings from in vivo microdialysis studies. Fundam. Clin. Pharmacol. 10 (1996) 16-27
17. Hughes J.R., Higgins S.T., and Bickel W.K. Nicotine withdrawal versus other drug withdrawal syndromes: similarities and dissimilarities. Addiction 89 (1994) 1461-1470
18. Isola R., Vogelsberg V., Wemlinger T.A., Neff N.H., and Hadjiconstantinou M. Nicotine abstinence in the mouse. Brain Res. 850 (1999) 189-196
19. Kennedy S.H., Evans K.R., Kruger S., Mayberg H.S., Meyer J.H., McCann S., Arifuzzman A.I., Houle S., and Vaccarino F.J. Changes in regional brain glucose metabolism measured with positron emission tomography after paroxetine treatment of major depression. Am. J. Psychiatry 158 6 (2001) 899-905
20. Kenny P.J., and Markou A. Neurobiology of the nicotine withdrawal syndrome. Pharmacol. Biochem. Behav. 70 (2001) 531-549
21. 1A receptor gene expression in the cerebral cortex and dorsal hippocampus. Eur. J. Neurosci. 13 (2001) 1267-1271
22. Kitamura Y., Araki H., Nagatani T., Takao K., Shibata K., and Gomita Y. Influence of imipramine on the duration of immobility in chronic forced-swim stressed rats. Acta Med. Okayama 58 6 (2004) 271-274
23. Linthorst A.C.E., Penalva R.G., Flachskamm C., Holsboer F., and Reul J.M.H.M. Forced swim stress activates rat hippocampal serotonergic neurotransmission involving a corticotropin-releasing hormone receptor-dependent mechanism. Eur. J. Neurosci. 16 (2002) 2441-2452
24. Markou A., Kosten T.R., and Koob G.F. Neurobiological similarities in depression and drug dependence: a self-medication hypothesis. Neuropsycopharmacology 18 (1998) 135-174
25. Mayberg H.S., Brannan S.K., Tekell J.L., Silva J.A., Mahurin R.K., McGinnis S., and Jerabek P.A. Regional metabolic effects of fluoxetine in major depression: serial changes and relationship to clinical response. Biol. Psychiatry 48 8 (2000) 830-843
26. Olausson P., Engel J.A., and Söderpalm B. Involvement of serotonin in nicotine dependence: processes relevant to positive and negative regulation of drug intake. Pharmacol. Biochem. Behav. 71 (2002) 757-771
27. Paperwalla K.N., Levin T.T., Weiner J., and Saravay S.M. Smoking and depression. Med. Clin. North Am. 88 6 (2004) 1483-1494
28. Peroutka S.J. 5-Hydroxytryptamine receptors. J. Neurochem. 60 (1993) 408-416
29. Porsolt R.D., Le Pichon M., and Jalfre M. Depression: a new model sensitive to antidepressant treatments. Nature 266 (1977) 730-732
30. Porsolt R.D., Anton G., Blavet N., and Jafre M. Behavioral despair in rats: a new model sensitive to antidepressant. Eur. J. Pharmacol. 47 (1978) 379-391
31. 3H]5-hydroxytryptamine release from rat striatal synaptosomes. Neuropharmacology 39 (2000) 290-299
32. Ribeiro E.B., Bettiker R.L., Bogdanov M., and Wurtam R.J. Effects of systemic nicotine on serotonin release in rat brain. Brain Res. 621 (1993) 311-318
33. Salin-Pascual R.J., Rosas M., Jimenez-Genchi A., Rivera-Meza B., and Delgado-Parra V. Antidepressant effect of transdermal nicotine patches in nonsmoking patients with major depression. J. Clin. Psychiatry 57 (1996) 387-389
34. Schmidt A.W., and Peroutka S.J. 5-Hydroxytryptamine receptor "families". FASEB J. 3 (1989) 2242-2249
35. Squadrito F., Calapai G., Campo G.M., Zingarelli B., Arcoraci V., Inoculano M., Buemi A.L., Cucinotta D., Saitta A., De Luca G., Gorini A., and Caputi A.P. Indolepyruvic acid, a tryptophan keto analogue, reduces food intake in obese Zucker rats. Neurosci. Res. Commun. 9 (1991) 27-36
36. G-nitro-l-arginine, an inhibitor of brain nitric oxide synthase, in obese Zucker rats. Eur. J. Pharmacol. 230 (1993) 125-128
37. Stolerman I.P., and Jarvis M.J. The scientific case that nicotine is addictive. Psychopharmacology 11 (1995) 2-10
38. 1B receptor antagonists and paroxetine or fluoxetine in the forced swimming test in rats. Pol. J. Pharmacol. 54 (2002) 615-623